PYK2 inhibitors (Pfizer)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamePYK2 inhibitors (Pfizer)

Drug Alias NameFAK 2 inhibitors (Pfizer)focal adhesion kinase 2 inhibitors (Pfizer)proline-rich tyrosine kinase 2 inhibitors (Pfizer)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFocal adhesion kinase 2 inhibitors

TargetsFocal adhesion kinase 2

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsOsteoporosis

ATC CodeN/A